Rethinking post-sepsis syndrome: linking cellular dysfunction to the clinical picture - Top-Institutions - MDSpire

Rethinking post-sepsis syndrome: linking cellular dysfunction to the clinical picture

  • By

  • Gabriel-Petre Gorecki

  • Andrei Bodor

  • Marius-Bogdan Novac

  • Dan-Gabriel Costea

  • Daniel-Ovidiu Costea

  • Andreea-Cristina Costea

  • Cătălin-Nicolae Grasa

  • Dana-Rodica Tomescu

  • October 2, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Critical Care Medicine
    • Immunology
    • Molecular Biology

  • #2

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Critical Care Medicine
    • Mitochondrial Biology
    • Immunology

  • #3

    Massachusetts General Hospital (MGH) / Harvard Medical School
    Massachusetts General Hospital (MGH) / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Critical Care Medicine
    • Immunology
    • Translational Medicine

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Critical Care Medicine
    • Mitochondrial Research
    • Immunology

Original Source(s)

Rethinking post-sepsis syndrome: linking cellular dysfunction to the clinical picture

  • by Gabriel-Petre Gorecki, Andrei Bodor, Marius-Bogdan Novac, Dan-Gabriel Costea, Daniel-Ovidiu Costea, Andreea-Cristina Costea, Cătălin-Nicolae Grasa, Dana-Rodica Tomescu

  • October 2, 2025

Related Content

Compliance of procalcitonin-guided antibiotic therapy in adult infectious patients in China: a multicenter real-world retrospective study

False-positive beta-glucan test due to beta-glucan component in sterile gauze during treatment of fungal sepsis: a case report

Targeting VISTA for immunomodulation in sepsis: mechanisms and therapeutic potentials